Meeting
2023 ASCO Annual Meeting
Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS.
Authors
Samuel Louis Cytryn
Memorial Sloan Kettering Cancer Center - Fellowship (GME Office), New York, NY
Samuel Louis Cytryn , David B. Solit , Henry S. Walch , Walid Khaled Chatila , Steven Brad Maron , Efsevia Vakiani , Angela Rose Brannon , Marc Ladanyi , Nikolaus Schultz , Michael F. Berger , Yelena Y. Janjigian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4036)
DOI
10.1200/JCO.2023.41.16_suppl.4036
Abstract #
4036
Poster Bd #
357
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
First Author: Tom Zhang
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive analysis of targetable alterations in urachal cancer by NGS.
First Author: David Joseph Benjamin
Poster
2023 ASCO Annual Meeting
Clinical implications of molecular alterations in intraductal carcinoma of the prostate.
First Author: Benjamin Miron
Poster
2022 ASCO Annual Meeting
Defining resistance mechanisms to CDK4/6 inhibition in hormone receptor-positive HER2-negative metastatic breast cancer (MBC) through a machine learning approach applied to circulating tumor DNA (ctDNA).
First Author: Lorenzo Gerratana